Ziphius - Crunchbase Company Profile & Funding

Q: Where is Ziphius's headquarters?

Ziphius is located in Merelbeke, Oost-Vlaanderen, Belgium.

Q: Who invested in Ziphius?

Ziphius is funded by Annie Vereecken.

Q: When was the last funding round for Ziphius?

Ziphius closed its last funding round on obfuscated from a Series A round.

Overview

Ziphius

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ziphius

CB Rank

67704

Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.

Founded

obfuscation

Private

Convertible Note

Merelbeke, Oost-Vlaanderen, Belgium

11-50

www.ziphius.org/

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Convertible Note

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Kristof Vercruysse: CSO
Tom Almey: COO

Details

Legal Name

Ziphius Vaccines NV

Also Known As

Ziphius Vaccines

Operating Status

Active

Company Type

For Profit

Founders

Chris Cardon, Kristof Vercruysse, Mathieu Ghadanfar, Tom Almey

About the Company

Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.

Contact Email

info@ziphius.org

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Self-amplifying RNA (saRNA) Platform

A technology that enables RNA to replicate itself within cells, increasing protein production at low doses for vaccines and therapies.

Lipid Nanoparticle (LNP) Delivery System

A lipid-based delivery system designed to encapsulate and deliver saRNA molecules efficiently into target cells.

Research & Development

Ziphius is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note
obfuscated obfuscation	Convertible Note - Ziphius	—	obfuscated obfuscation	—	Convertible Note

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Annie Vereecken	Yes	Series A - Ziphius	—
Annie Vereecken	Yes	Series A - Ziphius	—
Annie Vereecken	Yes	Series A - Ziphius	—
Annie Vereecken	Yes	Series A - Ziphius	—
Annie Vereecken	Yes	Series A - Ziphius	—